FULCRUM THERAPEUTICS
3.5700
07-十月-24 15:59:58
15 分钟延时
股票
-0.2500
-6.54%
今日范围
3.5500 - 3.7800
ISIN
N/A
来源
NASDAQ
-
Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
09 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 5月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Upcoming BofA Securities 2022 Healthcare Conference
05 5月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
02 5月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 4月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
17 3月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 3月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
03 3月 2022 07:01:00 条件 Nasdaq GlobeNewswire
-
03 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
24 2月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 2月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate in 11th Annual SVB Leerink Global Healthcare Conference
10 2月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
10 1月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 1月 2022 08:00:00 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Present at the 40th Annual J.P. Morgan Healthcare Conference
06 1月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Appoints Esther Rajavelu as Chief Financial Officer
04 1月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Appoints Sonja L. Banks to its Board of Directors
17 11月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Recent Business Highlights and Third Quarter 2021 Financial Results
04 11月 2021 07:00:02 条件 Nasdaq GlobeNewswire